About BioIntelliSense
BioIntelliSense is a company based in Redwood City (United States) founded in 2018 by David Wang and James Mault. BioIntelliSense has raised $140.05 million across 4 funding rounds from investors including Philips, UCHealth and Fresenius Medical Care. The company has 26 employees as of December 31, 2022. BioIntelliSense has completed 1 acquisition, including AlertWatch. BioIntelliSense operates in a competitive market with competitors including Withings, Tyto Care, iHealth Labs, Endotronix and Biotricity, among others.
- Headquarter Redwood City, United States
- Employees 26 as on 31 Dec, 2022
- Founders David Wang, James Mault
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biointellisense Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$140.05 M (USD)
in 4 rounds
-
Latest Funding Round
$58.05 M (USD), Series C
Dec 04, 2025
-
Investors
Philips
& 9 more
-
Employee Count
26
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioIntelliSense
Unlock access to complete
Funding Insights of BioIntelliSense
BioIntelliSense has successfully raised a total of $140.05M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $58.05 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioIntelliSense
BioIntelliSense has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Philips, UCHealth and Fresenius Medical Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private investment firm focused on regional opportunities.
|
Locked | Locked | Locked | |
|
Tech focused early stage VC firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for BioIntelliSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioIntelliSense
BioIntelliSense has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AlertWatch.
Investment portfolio details for BioIntelliSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Real-time patient monitoring software is provided for acute care clinicians.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for BioIntelliSense
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BioIntelliSense
Detailed financials for BioIntelliSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biointellisense Comparisons
Peer comparison for BioIntelliSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioIntelliSense
BioIntelliSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Tyto Care, iHealth Labs, Endotronix and Biotricity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
Detailed competitors of BioIntelliSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biointellisense
Complete news archive for BioIntelliSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioIntelliSense
BioIntelliSense was founded in 2018.
BioIntelliSense is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
David Wang is the current CEO of BioIntelliSense. They have also founded this company.
BioIntelliSense is a funded company, having raised a total of $140.05M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at BioIntelliSense is 26.
BioIntelliSense was established in 2018 in Redwood City, United States, within the healthcare technology sector. A single-use patch is developed for continuous vital signs monitoring, alongside a data-as-a-service platform, smart button, and smart sticker. These tools capture health data from a device attached to the upper left chest, enabling remote oversight by healthcare providers for patient management. Operations focus on integrating hardware with digital analytics for clinical use.
BioIntelliSense's top competitors include Withings, Tyto Care and Endotronix.
BioIntelliSense has made 1 acquisition, including AlertWatch.
BioIntelliSense has 10 investors. Key investors include Philips, UCHealth, Fresenius Medical Care, Triple Tree, and Chimera Investment.